Profiles

Keywords
Last Name
Institution

Connection

Kern Singh to Bone Morphogenetic Proteins

This is a "connection" page, showing publications Kern Singh has written about Bone Morphogenetic Proteins.

 
Connection Strength
 
 
 
3.789
 
  1. Ahn J, Jorgensen AY, Bohl DD, Tabaraee E, Rossi VJ, Aboushaala K, Singh K. Neuroforaminal Bone Growth Following Minimally Invasive Transforaminal Lumbar Interbody Fusion With BMP: A Computed Tomographic Analysis. Clin Spine Surg. 2017 Jul; 30(6):E754-E758.
    View in: PubMed
    Score: 0.637
  2. Singh K, Massel DH, Mayo BC, Bohl DD, Long WW, Modi KD. Bone Morphogenetic Proteins in Lumbar Arthrodesis: What Is All the Debate About? Commentary on an article by Daniel C. Beachler, PhD, MHS, et al.: "Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database". J Bone Joint Surg Am. 2016 07 06; 98(13):e57.
    View in: PubMed
    Score: 0.595
  3. Singh K, Nandyala SV, Marquez-Lara A, Fineberg SJ. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011. Spine (Phila Pa 1976). 2014 Mar 15; 39(6):491-6.
    View in: PubMed
    Score: 0.507
  4. Singh K, Ahmadinia K, Park DK, Nandyala SV, Marquez-Lara A, Patel AA, Fineberg SJ. Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature. Spine (Phila Pa 1976). 2014 Jan 01; 39(1):91-101.
    View in: PubMed
    Score: 0.500
  5. Fineberg SJ, Ahmadinia K, Oglesby M, Patel AA, Singh K. Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein. Spine (Phila Pa 1976). 2013 Jul 01; 38(15):1304-9.
    View in: PubMed
    Score: 0.483
  6. Singh K, Smucker JD, Ugbo JL, Tortolani PJ, Tsai L, Fei Q, Kuh S, Rumi M, Heller JG, Boden SD, Yoon ST. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin. Spine J. 2007 May-Jun; 7(3):326-31.
    View in: PubMed
    Score: 0.307
  7. Singh K, Smucker JD, Gill S, Boden SD. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech. 2006 Aug; 19(6):416-23.
    View in: PubMed
    Score: 0.299
  8. Marquez-Lara A, Nandyala SV, Fineberg SJ, Singh K. Current trends in demographics, practice, and in-hospital outcomes in cervical spine surgery: a national database analysis between 2002 and 2011. Spine (Phila Pa 1976). 2014 Mar 15; 39(6):476-81.
    View in: PubMed
    Score: 0.127
  9. Singh K, Marquez-Lara A, Nandyala SV, Patel AA, Fineberg SJ. Incidence and risk factors for dysphagia after anterior cervical fusion. Spine (Phila Pa 1976). 2013 Oct 01; 38(21):1820-5.
    View in: PubMed
    Score: 0.123
  10. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976). 2006 Nov 15; 31(24):2813-9.
    View in: PubMed
    Score: 0.076
  11. Takegami K, An HS, Kumano F, Chiba K, Thonar EJ, Singh K, Masuda K. Osteogenic protein-1 is most effective in stimulating nucleus pulposus and annulus fibrosus cells to repair their matrix after chondroitinase ABC-induced in vitro chemonucleolysis. Spine J. 2005 May-Jun; 5(3):231-8.
    View in: PubMed
    Score: 0.069
  12. An HS, Takegami K, Kamada H, Nguyen CM, Thonar EJ, Singh K, Andersson GB, Masuda K. Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine (Phila Pa 1976). 2005 Jan 01; 30(1):25-31; discussion 31-2.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.